Cancer
-
Protein discovery could lead to less toxic cancer drugs
Better, less toxic cancer drugs could be developed following the discovery into how a key protein involved in a wide range of cellular processes works, British scientists have reported. Read more
-
Plan to make some cancers "extinct"
The aim of modern cancer research must be to disrupt the “complex eco-systems” that the disease creates in the body, some of the UK’s leading researchers say today. Read more
-
Post-surgical radiotherapy may not improve long-term breast cancer survival
Radiotherapy after breast conserving surgery reduces the risk of the disease returning to the same breast over the following ten years but does not improve overall survival rates long term, a conference will hear today. Read more
-
Breast cancer conference draws researchers
Diabetes, physical fitness and early diagnosis have been among the early topics at a major European conference on breast cancer. Read more
-
European cancer epidemic warning
Cancer research must become a greater priority in order to avoid a European ‘epidemic’, experts warn today. Read more
-
Early cancer diagnosis improving and more to be done – NHS England
The NHS is making significant progress in diagnosing cancer at its early stages, NHS England said today. Read more
-
Hope for lung cancer halting protein
A protein is linked to mortality risk for lung cancer patients and might be a therapeutic target, according to a new study. Read more
-
Immune cells reprogrammed to destroy cancer
British scientists are working on a novel technique to reduce the support given by the immune system to growing cancer cells. Read more
-
Good results for new ovarian cancer surveillance approach
The use of a new algorithm for ovarian cancer surveillance in women at raised genetic risk can help delay preventive surgery, researchers report today. Read more
-
Genetic alternations in glioma brain cancers identified
A range of genetic alterations in glioma brain cancers have been identified that could affect adult brain cancer patients’ responses to treatment and survival. Read more
